These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cystatin C, and inhibitor of bone resorption produced by osteoblasts. Lerner UH, Johansson L, Ranjsö M, Rosenquist JB, Reinholt FP, Grubb A. Acta Physiol Scand; 1997 Sep; 161(1):81-92. PubMed ID: 9381954 [Abstract] [Full Text] [Related]
3. Interleukin-1 stimulates release of insulin-like growth factor-I from neonatal mouse calvaria by a prostaglandin synthesis-dependent mechanism. Linkhart TA, MacCharles DC. Endocrinology; 1992 Nov; 131(5):2297-305. PubMed ID: 1425428 [Abstract] [Full Text] [Related]
5. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer. Yoneda T, Williams P, Rhine C, Boyce BF, Dunstan C, Mundy GR. Cancer Res; 1995 May 01; 55(9):1989-93. PubMed ID: 7728770 [Abstract] [Full Text] [Related]
6. Suramin is a potent inhibitor of calcemic hormone- and growth factor-induced bone resorption in vitro. Farsoudi KH, Pietschmann P, Cross HS, Peterlik M. J Pharmacol Exp Ther; 1993 Feb 01; 264(2):579-83. PubMed ID: 8382276 [Abstract] [Full Text] [Related]
9. The anti-bone-resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation. Farley JR, Tarbaux NM, Hall SL, Linkhart TA, Baylink DJ. Endocrinology; 1988 Jul 01; 123(1):159-67. PubMed ID: 3383771 [Abstract] [Full Text] [Related]
10. IL-6 is produced by osteoblasts and induces bone resorption. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T. J Immunol; 1990 Nov 15; 145(10):3297-303. PubMed ID: 2121824 [Abstract] [Full Text] [Related]
12. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. Löwik CW, Nibbering PH, van de Ruit M, Papapoulos SE. J Clin Invest; 1994 Apr 15; 93(4):1465-72. PubMed ID: 8163651 [Abstract] [Full Text] [Related]
13. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors. Chikazu D, Shindo M, Iwasaka T, Katagiri M, Manabe N, Takato T, Nakamura K, Kawaguchi H. J Bone Miner Res; 2000 Apr 15; 15(4):674-82. PubMed ID: 10780859 [Abstract] [Full Text] [Related]
14. Human parathyroid hormone-related peptide-(107-111) does not inhibit bone resorption in neonatal mouse calvariae. Sone T, Kohno H, Kikuchi H, Ikeda T, Kasai R, Kikuchi Y, Takeuchi R, Konishi J, Shigeno C. Endocrinology; 1992 Dec 15; 131(6):2742-6. PubMed ID: 1306984 [Abstract] [Full Text] [Related]
15. Osteoblastic control of osteoclast bone resorption in a serum-free co-culture system. Lack of effect of parathyroid hormone. Teti A, Grano M, Colucci S, Zambonin Zallone A. J Endocrinol Invest; 1992 Dec 15; 15(9 Suppl 6):63-8. PubMed ID: 1300341 [No Abstract] [Full Text] [Related]
16. On the role of cyclic AMP as a mediator of bone resorption: gamma-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones. Lerner UH, Ransjö M, Ljunggren O, Klaushofer K, Hoffmann O, Peterlik M. J Bone Miner Res; 1991 Jun 15; 6(6):551-60. PubMed ID: 1653515 [Abstract] [Full Text] [Related]
19. Interleukin-1 and tumor necrosis factor-alpha induce collagenolysis and bone resorption by regulation of matrix metalloproteinase-2 in mouse calvarial bone cells. Kang BS, Park YG, Cho JY, Kim JK, Lee TK, Kim DW, Gu YH, Suzuki I, Chang YC, Kim CH. Immunopharmacol Immunotoxicol; 2003 Aug 15; 25(3):347-64. PubMed ID: 19180798 [Abstract] [Full Text] [Related]
20. Effects of parathyroid hormone and calcitonin on osteoclast formation in vitro. Feldman RS, Krieger NS, Tashjian AH. Endocrinology; 1980 Oct 15; 107(4):1137-43. PubMed ID: 7408763 [Abstract] [Full Text] [Related] Page: [Next] [New Search]